. Atglistatin effect in ATGL deficient animals. 8 weeks old ATGL deficient animals expressing ATGL exclusively in the heart (AKO/cTg) or wild type animals containing the heart transgene (WT/cTg) were fed a HFD in the presence or absence of Atglistatin. (a) Body weight was monitored throughout diet intervention. (b) Weights of adipose tissue depots were determined after 35 days of diet intervention. Data represent mean ± s.d. Statistical significance was determined by Student's two-tailed t test. For analysis of multiple measurements, we performed one-way analysis of variance (ANOVA) followed by Bonferroni post hoc test; P < 0.05 (*), P < 0.01 (**), and P < 0.001 (***) for control vs ATGLi; P < 0.05 ( # ), P < 0.01 ( ## ), and P < 0.001 ( ### ) for differences between genotypes. n=5-6 Supplementary Fig. 3 . Energy expenditure of ATGLi mice in relation to fat mass. 6 weeks old male C57Bl6J mice were fed a HFD (45 kJ% fat; 22.1 kJ/g) for 50 days. Thereafter, mice were fed a HFD in the presence and absence of Atglistatin for another 50 days. O 2 consumption and CO 2 production were determined using a laboratory animal monitoring system (LabMaster, TSE Systems, n=6 per group). Mice were familiarized with the metabolic cages for 3 days before measurement. Energy expenditure was calculated using the formula: EE(kJ/day)=15,818*VO 2 +5,176*VCO 2 /1000*24 and is plotted against fat mass. Linear regression analysis was performed using GraphPad prism software. Data represent single mice. (insert) Energy expenditure is expressed as adjusted means based on a normalized body mass of 8.5 g determined using ANCOVA, p=0.64. Data represent mean + s.d. (c) Core body temperature was assessed on 4 consecutive days after 6 and 10 weeks of diet intervention starting 2 weeks after implanting telemetry sensors into the abdominal cavity of mice (n=5 per group). (d-h) Male mice were fed a HFD for 14 weeks at an ambient temperature of 21-23°C and acclimatized to 30°C for further 2 weeks prior to intervention using Atglistatin HFD. The control group was switched to pair-feeding regimen receiving the mean daily food intake of ATGLi group from day 0 onwards. Time-course of (d) relative body weight, (e) total fat mass, and (f) lean mass. (g) Tissue weights of 2 h re-fed animals. (h) Histological images of interscapular BAT (iBAT) of control pair-fed and ATGLi animals (Scale bar 100 µm). Data are presented as mean +/-s.d. Statistical significance was determined using Student's t-test between ATGLi HFD and control HFD ad lib, or ATGLi HFD and control HFD pair-fed. P < 0.05 (*), P < 0.01 (**), and P < 0.001 (***), n = 6-7. Supplementary Fig. 6 . Atglistatin treatment improves glucose homeostasis. 6 weeks old male C57Bl6J mice were fed a HFD (45 kJ% fat; 22.1 kJ/g) for 50 days. Thereafter, mice were fed a HFD in the presence and absence of Atglistatin for 6 weeks. (a)Insulin sensitivity and (b) glucose tolerance was determined after 50 days HFD-feeding before Atglistatin treatment (0 weeks) and 6 weeks after Atglistatin treatment (on a HFD) by intraperitoneal injection of 0.5 IU/kg insulin and 1.5 g/kg glucose, respectively (n=6). Area under the curve (AUC) was calculated using GraphPad Prism software. Data represent mean + s.d. Statistical significance between 0 and 6 weeks was determined by two-tailed student's ttest; *P<0.05; **P<0.01. Supplementary Fig.8 . Liver TG of Atglistatin treated ATGL deficient animals. 8 weeks old ATGL deficient animals expressing ATGL exclusively in the heart (AKO/cTg) or wild type animals containing the heart transgene (WT/cTg) were fed a HFD in the presence or absence of Atglistatin. Total lipids were extracted and acylglycerol levels were determined in livers of WT/cTg and AKO/cTg mice after 35 days of diet intervention. 
